Rituximab as first line treatment for MALT lymphoma of extraocular muscles

dc.contributor.authorBenetatos, L.en
dc.contributor.authorAlymara, V.en
dc.contributor.authorAsproudis, I.en
dc.contributor.authorBourantas, K. L.en
dc.date.accessioned2015-11-24T18:53:18Z
dc.date.available2015-11-24T18:53:18Z
dc.identifier.issn0939-5555-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18537
dc.rightsDefault Licence-
dc.subjectAntibodies, Monoclonal/*administration & dosageen
dc.subjectAntibodies, Monoclonal, Murine-Deriveden
dc.subjectAntineoplastic Agents/*administration & dosageen
dc.subjectHumansen
dc.subjectLymphoma, B-Cell, Marginal Zone/*drug therapy/pathologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectMuscle Neoplasms/*drug therapy/pathologyen
dc.subject*Oculomotor Muscles/pathologyen
dc.subjectRemission Inductionen
dc.subjectStomach Neoplasms/drug therapy/pathologyen
dc.subjectTime Factorsen
dc.titleRituximab as first line treatment for MALT lymphoma of extraocular musclesen
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1007/s00277-006-0134-0-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16691396-
heal.identifier.secondaryhttp://www.springerlink.com/content/f3t8784117343k47/fulltext.pdf-
heal.journalNameAnn Hematolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: